Exp Clin Endocrinol Diabetes 1986; 88(6): 270-274
DOI: 10.1055/s-0029-1210606
Original

© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York

Rat Hypothalamus Contains an Antimitogenic Factor Acting Via Benzodiazepine Receptors

M. Pawlikowski, H. Stepień, J. Kunert-Radek
  • Institute of Endocrinology (Head: Prof. Dr. M. Pawlikowski) Medical Academy of Łódź/Poland
Further Information

Publication History

1986

Publication Date:
16 July 2009 (online)

Summary

The effect of crude rat hypothalamic extracts on the lymphocyte proliferation in vitro was investigated. It was found that hypothalamic extracts (HE) significantly inhibited the 3H-thymidine incorporation by the mouse spleen lymphocytes cultured in vitro. The factor (or factors) responsible for the antimitogenic effect is thermostabile and partially destroyable by trypsin digestion. The latter observation suggests that it is probably a peptide. Diazepam had been found to exert a similar antimitogenic effect on mouse spleen lymphocytes as HE. The putative endogenous benzodiazepine (BZD) receptor ligand is also assumed to be a peptide. The working hypothesis that the antimitogenic effect of HE depends on endogenous substance acting via BZD receptor was proposed. To test such a possibility, the interaction of HE and specific BZD receptor ligands Ro-15-1788 and Ro-5-4864 was investigated. It was found that Ro-5-4864 alone suppressed the lymphocyte proliferation, and the joint antiproliferative effect of HE and Ro-5-4864 was not additive. Ro-15-1788 alone did not influence the lymphocyte proliferation but abolished the antiproliferative effect of HE. These data suggest that antimitogenic factor present in HE acts via BZD receptors.

    >